Speaker

Barbara Binzak Blumenfeld

Ms. Barbara Binzak Blumenfeld

Shareholder
Buchanan Ingersoll & Rooney PC
United States

Barbara A. Binzak Blumenfeld, Ph.D. focuses her practice on clients whose products are subject to Food and Drug Administration (FDA) regulations. Since joining Buchanan in March 2003, Dr. Binzak Blumenfeld has capitalized on her unique background, integrating her knowledge of molecular biology and bioethics into her legal practice. She has published and spoken on a wide variety of topics that include investigational new drugs, new and generic drugs, and biologics such as cell and gene therapies. Dr. Binzak Blumenfeld advises her clients on product life cycle, compliance, and enforcement matters at all stages of their interactions with FDA.

DAY I, 18TH JANUARY 2019, FRIDAY

11:30 am to 1:00 pm

Plenary Session II - Regulatory Provisions of USFDA for Approval of Pharma & Biosimilar Drugs

Scarlet

Know More